10.43
price down icon2.09%   -0.2225
after-market After Hours: 10.38 -0.0499 -0.48%
loading

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Forecast

The Proshares Ultrashort Health Care 2 X Shares (RXD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.2867, representing a -78.08% decrease from the current price of $10.43. The highest analyst price target is $4.3098, and the lowest is $0.2637.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RXD Price Target
Average 12.93 (+23.96% Upside)
loading

Is Proshares Ultrashort Health Care 2 X Shares (RXD) A Buy Now?

Oscillators
Name Value Action
RSI(14) 35.19 Neutral
STOCH(9,6) 7.7562 Buy
STOCHRSI(14) 15.62 Buy
MACD(12,26) -0.226 Sell
ADX(14) 28.54 Sell
William %R -95.08 Buy
CCI(14) -92.07 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
10.88
Sell
10.82
Sell
MA20
11.24
Sell
11.06
Sell
MA50
11.25
Sell
11.06
Sell
MA100
10.53
Sell
10.82
Sell
MA200
10.51
Sell
10.85
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, RXD could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RXD, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 35.19 indicates that RXD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 7.7562 indicates that RXD is oversold. This indicates that RXD price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.62 indicates that RXD is oversold. This suggests that RXD price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.54 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -92.07 indicates that RXD is still oversold but not to an extreme extent.

Long-term RXD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Proshares Ultrashort Health Care 2 X Shares financial reports and earnings history, Proshares Ultrashort Health Care 2 X Shares (RXD) stock could reach $25.76 by 2030, $30.33 by 2040 and $89.18 by 2050. See the projected annual prices until 2050 of the Proshares Ultrashort Health Care 2 X Shares stock below:

  • Proshares Ultrashort Health Care 2 X Shares (RXD) is expected to reach an average price of $9.2393 in 2035, with a high prediction of $9.0918 and a low estimate of $9.2177. This indicates an $-11.42% rise from the last recorded price of $10.43.
  • Proshares Ultrashort Health Care 2 X Shares (RXD) stock is projected to chart a bullish course in 2040, with an average price target of $29.59, representing an $183.73% surge from its current level. The forecast ranges from a conservative $29.74 to a sky-high $30.33.
  • Our analysts predict Proshares Ultrashort Health Care 2 X Shares (RXD) to jump 434.86% by 2045, soaring from $55.41 to an average price of $55.79, potentially reaching $55.71. While $55.41 is the low estimate, the potential upside is significant.
  • Proshares Ultrashort Health Care 2 X Shares (RXD) stock is expected to climb by 2050, reaching an average of $88.25, a $746.16% jump from its current level. However, a wide range of estimates exists, with high and low targets of $89.18 and $88.66, respectively, highlighting the market's uncertainty.

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Year by Year Forecast

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2025

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) is expected to reach an average price of $12.93 in 2025, with a high prediction of $25.59 and a low estimate of $0.2637. This indicates an +23.96% rise from the last recorded price of $10.43.
Month Average Low High Change from today's price
February, 2025 $4.0898 $0.2637 $4.3098 -60.79%
March, 2025 $9.6221 $0.5559 $11.14 -7.75%
April, 2025 $6.4674 $2.8752 $25.59 -37.99%
May, 2025 $2.7403 $2.7734 $9.6805 -73.73%
June, 2025 $3.068 $1.6142 $2.2272 -70.58%
July, 2025 $3.4827 $3.6827 $3.1488 -66.61%
August, 2025 $3.6104 $3.5565 $3.1635 -65.38%
September, 2025 $5.9381 $6.0781 $5.5581 -43.07%
October, 2025 $5.0928 $6.105 $6.1058 -51.17%
November, 2025 $5.4405 $4.4536 $4.6066 -47.84%
December, 2025 $3.3152 $5.4674 $5.7213 -68.21%

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2026

The predicted value for Proshares Ultrashort Health Care 2 X Shares (RXD) in 2026 is set at an average of $8.7404. Estimates vary from a peak of $10.78 to a trough of $6.7029, indicating an -16.20% surge from the present price of $10.43.
Month Average Low High Change from today's price
January, 2026 $6.7029 $6.7029 $6.709 -35.73%
February, 2026 $7.8706 $6.7698 $7.1637 -24.54%
March, 2026 $8.9783 $7.6775 $8.6183 -13.92%
April, 2026 $8.253 $8.7791 $9.0853 -20.87%
May, 2026 $7.8207 $7.7738 $7.4607 -25.02%
June, 2026 $8.2684 $8.0215 $7.9015 -20.72%
July, 2026 $9.1831 $9.2754 $9.0823 -11.95%
August, 2026 $9.3908 $9.2239 $8.9769 -9.96%
September, 2026 $10.02 $9.4477 $9.7355 -3.97%
October, 2026 $10.53 $10.06 $10.35 +0.99%
November, 2026 $10.71 $10.59 $10.68 +2.65%
December, 2026 $8.7956 $9.5155 $10.78 -15.67%

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Proshares Ultrashort Health Care 2 X Shares (RXD) is $6.7431, with a high forecast of $9.6995 and a low forecast of $3.7867. This indicates an -35.35% decrease from the last price of $10.43.
Month Average Low High Change from today's price
January, 2027 $9.2683 $8.7725 $8.3325 -11.14%
February, 2027 $9.1263 $9.4402 $9.4584 -12.50%
March, 2027 $9.465 $8.5226 $8.8057 -9.25%
April, 2027 $8.225 $8.8148 $9.6995 -21.14%
May, 2027 $7.5091 $7.2272 $7.3111 -28.00%
June, 2027 $6.4028 $6.8858 $7.008 -38.61%
July, 2027 $8.0318 $7.9937 $7.8269 -22.99%
August, 2027 $6.0674 $6.9412 $7.8874 -41.83%
September, 2027 $6.1502 $5.6551 $6.0823 -41.03%
October, 2027 $5.4736 $3.7867 $5.4428 -47.52%
November, 2027 $5.3813 $5.4974 $4.9205 -48.41%
December, 2027 $5.5195 $5.4182 $5.429 -47.08%

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2028

In 2028, Proshares Ultrashort Health Care 2 X Shares (RXD) is projected to reach an average price of $2.6627, with a high projection of $4.8907 and a low estimate of $0.4348. This indicates an -74.47% fall from the last price of $10.43.
Month Average Low High Change from today's price
January, 2028 $4.7623 $4.1753 $4.3629 -54.34%
February, 2028 $2.8214 $3.2845 $3.8406 -72.95%
March, 2028 $3.9722 $3.2783 $4.4092 -61.92%
April, 2028 $5.101 $4.6199 $4.4312 -51.09%
May, 2028 $4.2681 $4.4584 $4.8907 -59.08%
June, 2028 $3.4463 $3.9962 $3.7555 -66.96%
July, 2028 $2.8819 $3.1612 $3.21 -72.37%
August, 2028 $1.0601 $1.5585 $2.0108 -89.84%
September, 2028 $2.5249 $1.6155 $2.1563 -75.79%
October, 2028 $1.6516 $1.8537 $2.1732 -84.16%
November, 2028 $0.7336 $0.4348 $1.0809 -92.97%
December, 2028 $0.2023 $0.7798 $0.8433 -98.06%

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2029

The 2029 price forecast for Proshares Ultrashort Health Care 2 X Shares Stock (RXD) is $11.88 on average, with a high prediction of $23.76 and a low estimate of $0.00567. This represents an +13.92% increase from the previous price of $10.43.
Month Average Low High Change from today's price
January, 2029 $0.3077 $0.5889 $0.996 -97.05%
February, 2029 $0.052 $0.2618 $0.3149 -99.50%
March, 2029 $0.8341 $0.00567 $0.8935 -92.00%
April, 2029 $1.7171 $0.8039 $1.7858 -83.54%
May, 2029 $2.2512 $1.8889 $3.102 -78.42%
June, 2029 $1.9081 $1.7842 $2.3692 -81.71%
July, 2029 $0.8621 $0.7757 $1.9715 -91.73%
August, 2029 $0.9611 $0.6288 $1.5418 -90.79%
September, 2029 $0.9634 $0.4379 $1.1672 -90.76%
October, 2029 $0.9173 $0.8731 $1.3756 -91.21%
November, 2029 $2.5452 $1.2096 $2.6979 -75.60%
December, 2029 $24.15 $2.4372 $23.76 +131.57%

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) Price Forecast for 2030

Proshares Ultrashort Health Care 2 X Shares Stock (RXD) is expected to reach an average price of $25.74 in 2030, with a high forecast of $30.92 and a low forecast of $20.56. This signifies an +146.76% surge from the last price of $10.43.
Month Average Low High Change from today's price
January, 2030 $28.60 $24.50 $25.76 +174.22%
February, 2030 $26.34 $27.32 $27.17 +152.51%
March, 2030 $25.41 $25.41 $25.75 +143.65%
April, 2030 $24.33 $24.19 $22.89 +133.25%
May, 2030 $22.58 $22.70 $23.64 +116.46%
June, 2030 $25.85 $23.17 $23.87 +147.87%
July, 2030 $29.28 $26.14 $28.42 +180.75%
August, 2030 $31.08 $29.66 $30.92 +197.96%
September, 2030 $31.81 $30.95 $30.27 +205.01%
October, 2030 $30.44 $30.32 $30.33 +191.87%
November, 2030 $12.34 $20.56 $22.37 +18.29%
December, 2030 $45.93 $23.31 $25.23 +340.40%
exchange_traded_fund VTV
$177.77
price up icon 1.05%
exchange_traded_fund VUG
$419.95
price up icon 0.14%
exchange_traded_fund IJH
$65.25
price up icon 1.10%
exchange_traded_fund EFA
$79.99
price up icon 1.10%
exchange_traded_fund IWF
$410.73
price up icon 0.29%
exchange_traded_fund QQQ
$523.05
price up icon 0.43%
Cap:     |  Volume (24h):